Start SIP in MEDPLUS
Start SIPPerformance
- Low
- ₹723
- High
- ₹739
- 52 Week Low
- ₹599
- 52 Week High
- ₹876
- Open Price₹725
- Previous Close₹725
- Volume298,534
Investment Returns
- Over 1 Month -12.92%
- Over 3 Month + 12.57%
- Over 6 Month + 7.72%
- Over 1 Year + 1.95%
Smart Investing Starts Here Start SIP with Medplus Health Services for Steady Growth!
Medplus Health Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 87.5
- PEG Ratio
- 1.2
- Market Cap Cr
- 8,767
- P/B Ratio
- 5.4
- Average True Range
- 30.04
- EPS
- 8.37
- Dividend Yield
- 0
- MACD Signal
- -18.74
- RSI
- 37.8
- MFI
- 29.55
Medplus Health Services Financials
Medplus Health Services Technicals
EMA & SMA
Current Price
₹732.45
+
7.15
(0.99%)
- Bullish Moving Average 4
- Bearish Moving Average 12
- 20 Day
- ₹766.96
- 50 Day
- ₹777.35
- 100 Day
- ₹756.06
- 200 Day
- ₹736.13
Resistance and Support
731.48
- R3 755.97
- R2 747.48
- R1 739.97
- S1 723.97
- S2 715.48
- S3 707.97
Medplus Health Services Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-31 | Quarterly Results | |
2024-11-12 | Quarterly Results | |
2024-08-02 | Quarterly Results | |
2024-05-28 | Audited Results | |
2024-02-21 | Others | Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023. |
Medplus Health Services F&O
About Medplus Health Services
- NSE Symbol
- MEDPLUS
- BSE Symbol
- 543427
- ISIN
- INE804L01022
Similar Stocks to Medplus Health Services
Medplus Health Services FAQs
Medplus Health Services share price is ₹732 As on 31 January, 2025 | 03:19
The Market Cap of Medplus Health Services is ₹8767 Cr As on 31 January, 2025 | 03:19
The P/E ratio of Medplus Health Services is 87.5 As on 31 January, 2025 | 03:19
The PB ratio of Medplus Health Services is 5.4 As on 31 January, 2025 | 03:19
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.